It’s one of the holy grails of cardiology, and indeed all of medicine – are we able to regenerate cardiac tissue? Cardiomyopathy of any type is difficult to manage, is the direct cause of a great deal of morbidity and mortality, and remains relatively poorly understood, regardless of aetiology. The potential to generate new cells or to reprogram existing ones could change the face of this disease.
This review in Nature gives a broad overview of where we are now and what challenges lie to turn this concept into a feasibility, although you may be surprised at how far we have come. Read it here.
source | Nature Medicine
image | Human Pathology